Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases

Cancer

Volumn 89, Issue 3, 2000, Pages 488-499

  Bruns, Christiane J ^a   Liu, Wenbiao ^a   Davis, Darren W ^a   Shaheen, Raymond M ^a   McConkey, David J ^a   Wilson, Michael R ^a   Bucana, Corazon D ^a   Hicklin, Daniel J ^b   Ellis, Lee M ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Angiogenesis; Antibodies; Apoptosis; Colon carcinoma; Endothelial cells; Immunohistochemistry; Metastasis; Receptor; Vascular endothelial growth factor; Vascular endothelial growth factor receptor 2

Indexed keywords

MONOCLONAL ANTIBODY DC101; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2 ANTIBODY;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LIVER METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; APOPTOSIS; CELL SURVIVAL; COLONIC NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LYMPHOKINES; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034255151     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000801)89:3<488::AID-CNCR3>3.0.CO;2-X     Document Type: Article

References (45)

1. Angiogenesis in cancer, vascular, rhuematoid and other disease
2. The biology of vascular endothelial growth factor
3. Downregulation of vascular endothelial growth factor in human colon carcinoma cell lines by antisense transfection decreases endothelial cell proliferation
4. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
5. Vessel counts and VEGF expression as prognostic factors in node-negative colon cancer
6. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis
7. Halting angiogenesis suppresses carcinoma cell invasion
8. Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy
9. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders
10. Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor
11. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor
12. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor
13. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo
14. Flk-1 as a target for tumor growth inhibition
15. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation
16. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
17. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice
18. In vitro neutralization of vascular endothelial growth factor activation of flt-1 by a monoclonal antibody
19. Tumor angiogenesis and metastasis-correlation in invasive breast cancer
20. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
21. Regulation of vascular endothelial growth factor receptor KDR in vitro by a soluble factor in confluent endothelial cells
22. The implications of angiogenesis to the biology and therapy of cancer metastasis
23. Regulation of distinct steps of angiogenesis by different angiogenic molecules
24. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
25. Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma
26. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
27. Glioblastoma growth inhibited in vivo by a dominant-negative flk-1 mutant
28. Vascular endothelial growth factor and its receptors
29. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium
30. Mutant ras oncogenes upregulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis
31. Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-src
32. Adenovirally-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer
33. p53, vessel count, and vascular endothelial growth factor expression in human colon cancer
34. The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways
35. Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I
36. Regulation of vascular endothelial growth factor expression in human colon cancer by interleukin-1β
37. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis
38. Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by cell density
39. Modulation of VEGF production by pH and glucose in retinal Muller cells
40. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-α: Balance between growth and death signals
41. Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation
42. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression
43. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types
44. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
45. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity